Doxycycline hyclate 100 MG VLS
Ended Awarded
- Contract number
- SPE2D325F214L
- Awardee
-
Hikma Pharmaceuticals USA Inc. UEI NQJ5E87TKNB1 Part of Hikma Specialty USA Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,413
Award facts
- Contract value 100% obligated
- $1,413.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Berkeley Heights, NJ 07922, USA
Award details come from SAM.gov/FPDS.
About this award
Hikma Pharmaceuticals USA Inc. (formerly West-Ward Pharmaceuticals) was awarded a delivery order valued at $1,413.04 for Doxycycline Hyclate 100 mg by the Medical Supply Chain, a defense-oriented federal agency, on July 14, 2025. This firm fixed-price delivery order is scheduled for completion by July 15, 2025, with performance conducted at the contractor's facility in Berkeley Heights, New Jersey. No small business set-aside designation was utilized for this award. The contract represents a continuation of Hikma's established role as a critical pharmaceutical supplier to federal government healthcare systems.
This delivery order is likely issued under one of Hikma's existing Indefinite Delivery Vehicles, including the company's $216 million multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs or its $38.5 million Blanket Purchase Agreement with the National Acquisition Center, both covering pharmaceuticals and drugs under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. Doxycycline hyclate is a commonly prescribed antibiotic essential for military treatment facilities and VA healthcare networks. Hikma's extensive portfolio of federal contracts demonstrates its established capacity to supply critical medications to defense and veterans' healthcare systems on a consistent and reliable basis.
Quick answers
Who was awarded contract SPE2D325F214L?
SPE2D325F214L was awarded to Hikma Pharmaceuticals USA Inc. by Medical Supply Chain (Troop Support) on July 14, 2025.
How much is contract SPE2D325F214L worth?
The government has obligated $1,413 on SPE2D325F214L.
Is contract SPE2D325F214L an order under another contract?
Yes. SPE2D325F214L is a delivery order under SPE2D020D0006, an indefinite delivery contract.
Was contract SPE2D325F214L competed?
The extent of competition for SPE2D325F214L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award